Surveillance study on the tolerability and safety of Flebogamma® DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients.

about

Surveillance study on the tolerability and safety of Flebogamma® DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients.

Item

http://www.wikidata.org/entity/Q42183204

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Surveillance study on the tole ...... adult and pediatric patients.

@en

Surveillance study on the tolerability and safety of Flebogamma® DIF

@nl

type

Item

label

Surveillance study on the tole ...... adult and pediatric patients.

@en

Surveillance study on the tolerability and safety of Flebogamma® DIF

@nl

prefLabel

Surveillance study on the tole ...... adult and pediatric patients.

@en

Surveillance study on the tolerability and safety of Flebogamma® DIF

@nl

P1476

Surveillance study on the tole ...... adult and pediatric patients.

@en

P2093

Andreas Mohr

http://www.w3.org/2001/XMLSchema#string

Elizabeth Drewe

http://www.w3.org/2001/XMLSchema#string

Esperanza Martín

http://www.w3.org/2001/XMLSchema#string

Georg Günther

http://www.w3.org/2001/XMLSchema#string

Jaime Pons

http://www.w3.org/2001/XMLSchema#string

Jens Papke

http://www.w3.org/2001/XMLSchema#string

Maria Montañés

http://www.w3.org/2001/XMLSchema#string

Mark Gompels

http://www.w3.org/2001/XMLSchema#string

Ronnie Chee

http://www.w3.org/2001/XMLSchema#string

Xènia Oliver

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in adult chronic ITP.

IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life.

How I treat idiopathic thrombocytopenic purpura (ITP).

Clinical and investigational considerations for the use of IGIV therapy.

Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpura.

Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura.

Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.

Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia.

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.

A study of adverse drug reactions in pediatric patients.

P31

scholarly article

P356

10.1002/PRP2.345

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Laia Alsina

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28971614

http://www.w3.org/2001/XMLSchema#string

P932

5625155

http://www.w3.org/2001/XMLSchema#string